Showing results (3131-3140 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|November 9, 2016
Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysisSheng Zhao, Yanping Miao, Ruijun Wang, et al.
Oncotargets and Therapy|November 9, 2016
Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysisZhen Chen, Yingjie Shao, Kun Wang, et al.
Oncotargets and Therapy|November 10, 2016
High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinomaLingfu Zhang, Dianrong Xiu, Jun Zhan, et al.
Oncotargets and Therapy|November 10, 2016
A current perspective on stereotactic body radiation therapy for pancreatic cancerJulian C Hong, Brian G Czito, Christopher G Willett, et al.
Oncotargets and Therapy|October 13, 2016
Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinomaHui Fu, Lisha Qi, Lu Chen, et al.
Oncotargets and Therapy|October 21, 2016
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancerFen Liu, Feiyan Ai, Li Tian, et al.
Oncotargets and Therapy|November 2, 2016
Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinomaPeng Sun, Fei Zhang, Cui Chen, et al.
Oncotargets and Therapy|November 2, 2016
Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER databaseMin-Qiang Lin, Yue-Ping Li, San-Gang Wu, et al.
Oncotargets and Therapy|November 2, 2016
Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gelsDhairya H Patel, Neeti Sharma
Oncotargets and Therapy|November 2, 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of ChinaJianlin Xu, Guozheng Ding, Xueyan Zhang, et al.
Pageof 674